Variables | OR | 95%CI | p value |
---|---|---|---|
Age | 1.0005 | 0.9923–1.0183 | 0.4303 |
Female | 1.7759 | 1.1951–2.6826 | 0.0054* |
Disease duration | 0.9979 | 0.9965–0.9993 | 0.0041* |
Steinbrocker stage | 1.1723 | 0.9972–1.3786 | 0.0540 |
Steinbrocker class | 2.4559 | 1.9617–3.0942 | <0.0001* |
ACPA | 1.0008 | 1.0001–1.0016 | 0.0211* |
MTX usage | 1.0330 | 0.7607–1.4072 | 0.8356 |
PSL usage | 1.8142 | 1.3524–2.4352 | <0.0001* |
Biologics/JAK usage | 0.4870 | 0.3431–0.6849 | <0.0001* |
Hypertension | 1.0769 | 0.7698–1.5013 | 0.6632 |
Diabetes mellitus | 1.2927 | 0.7782–2.1835 | 0.3182 |
Respiratory disease | 1.4247 | 0.9261–2.1846 | 0.1053 |
Cerebrovascular disease | 1.8682 | 1.0642–3.6347 | 0.0334* |
Cardiovascular disease | 1.5137 | 0.8919–2.5645 | 0.1229 |
Renal disease | 1.1947 | 0.8229–1.7320 | 0.3479 |
Malignant tumor | 0.7047 | 0.3762–1.2753 | 0.2590 |